BEYRIZO

View On IC.GC.CA

ADVERTISED

on 18 Dec 2024

Last Applicant/ Owned by

Takeda Pharmaceuticals International AG

Thurgauerstrasse 130CH-8152 Glattpark-Opfikon

Serial Number

2199217 filed on 7^th Apr 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

BEYRIZO

Trademark usage description

préparations pharmaceutiques pour le traitement des crises de convulsions associées au syndrome de dravet et au syndrome de lennox-gastaut.

Classification Information

2199217

Trademark

Action Taken	Status
Submitted for opposition 48 on 15^th Jan 2024	Agent Changed
Submitted for opposition 22 on 26^th Oct 2023	Search Recorded
Submitted for opposition 20 on 26^th Oct 2023	Examiner's First Report
Submitted for opposition 223 on 26^th Oct 2023	Total Provisional Refusal
Submitted for opposition 256 on 22^nd May 2023	Notification of Possible Opposition Sent
Submitted for opposition 257 on 21^st Jul 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 20^th Jul 2022	Created
Submitted for opposition 31 on 20^th Jul 2022	Formalized
Submitted for opposition 30 on 7^th Apr 2022	Filed
Submitted for opposition 228 on 7^th Apr 2022	International Registration